{"id":749501,"date":"2023-04-20T08:29:39","date_gmt":"2023-04-20T12:29:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/"},"modified":"2023-04-20T08:29:39","modified_gmt":"2023-04-20T12:29:39","slug":"proqr-announces-upcoming-investor-conferences-in-april-and-may","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/","title":{"rendered":"ProQR Announces Upcoming Investor Conferences in April and May"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April  20, 2023  (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer\u00ae RNA editing technology platform, today announced that Company management will participate in the following upcoming investor conferences and events.<\/p>\n<ul>\n<li>\n          <strong>Van Lanschot Kempen Life Sciences Conference \u2013 Amsterdam<br \/><\/strong>Wednesday, April 26 \u2013 1&#215;1 meetings only<\/p>\n<\/li>\n<li>\n          <strong>JMP Securities Life Sciences Conference \u2013 New York<br \/><\/strong>Tuesday, May 16, 12:30-12:50pm EDT \u2013 Fireside chat and 1&#215;1 meetings<\/p>\n<\/li>\n<li>\n          <strong>Stifel 2023 Tailoring Genes: Genetic Medicines Day \u2013 Virtual<br \/><\/strong>Tuesday, May 30, time TBC \u2013 Fireside chat only<\/p>\n<\/li>\n<\/ul>\n<p>Where applicable, presentation and webcast details will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EdfDAdGbG2TTh4edTGnQWCirjClVV-es96aUxFPwZhoD8yDISLI-2P47xX0AmyETFT5X7d0muxNtlKkqtag-RA==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>Events<\/u><\/b><\/strong><\/a>\u201d. Archived webcasts will be available for approximately 30 days following the presentation date.<\/p>\n<p>\n        <b>About Axiomer<sup>\u00ae<\/sup><\/b>\n      <\/p>\n<p>ProQR is pioneering a next-generation RNA base editing technology called Axiomer<sup>\u00ae<\/sup>, which could potentially yield a new class of medicines for diverse types of diseases. Axiomer<sup>\u00ae<\/sup> \u201cEditing Oligonucleotides\u201d, or EONs, mediate single nucleotide changes to RNA in a highly specific and targeted way using molecular machinery that is present in human cells called ADAR (Adenosine Deaminase Acting on RNA). Axiomer<sup>\u00ae<\/sup> EONs are designed to recruit and direct endogenously expressed ADARs to change an Adenosine (A) to an Inosine (I) in the RNA \u2013 an Inosine is translated as a Guanosine (G) \u2013 correcting an RNA with a disease-causing mutation back to a normal (wild type) RNA, modulating protein expression, or altering a protein so that it will have a new function that helps prevent or treat disease.<\/p>\n<p>\n        <b>About ProQR<\/b>\n      <\/p>\n<p>ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies. ProQR is pioneering a next-generation RNA technology called Axiomer<sup>\u00ae<\/sup>, which uses a cell\u2019s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.<\/p>\n<p>Learn more about ProQR at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CCy6LDj0bcPYzm2wy9Zai5_33TmDoq0YuLaMibrXtFGZJkFzL71Ulk0WXJrOTtETVGiqsqArxhy-MsVlC72GtA==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>www.proqr.com<\/u><\/b><\/strong><\/a>.<\/p>\n<p>\n        <b>Forward Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;look forward to&#8221;, &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions. Such forward-looking statements include, but are not limited to, statements regarding our participation in these conferences, our business, our technology, our strategy, our Axiomer platform, and our product candidates and their therapeutic potential. Forward-looking statements are based on management&#8217;s beliefs and assumptions and on information available to management only as of the date of this press release. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including certain sections of our annual report filed on Form 20-F. These risks and uncertainties include, among others, the cost, timing and results of preclinical studies and clinical trials and other development activities by us and our collaborative partners; the likelihood of our preclinical and clinical programs being initiated and executed on timelines provided and reliance on our contract research organizations and predictability of timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our reliance on contract manufacturers to supply materials for research and development and the risk of supply interruption from a contract manufacturer; the potential for future data to alter initial and preliminary results of early-stage clinical trials; the unpredictability of the duration and results of the regulatory review of applications or clearances that are necessary to initiate and continue to advance and progress our clinical programs; the ability to secure, maintain and realize the intended benefits of collaborations with partners, including the collaboration with Lilly; the possible impairment of, inability to obtain, and costs to obtain intellectual property rights; possible safety or efficacy concerns that could emerge as new data are generated in research and development; and general business, operational, financial and accounting risks, and risks related to litigation and disputes with third parties. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.<\/p>\n<p>\n        <b>ProQR Therapeutics N.V.<\/b>\n      <\/p>\n<p>\n        <b>Investor contact:<\/b><br \/>\n        <br \/> Sarah Kiely<br \/> ProQR Therapeutics N.V.<br \/> T: +1 617 599 6228<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s97b7aM8Q7cftI_mw7HiZWYrF-pGf1JLLzxEfWqZU00Uihxh_wp84u6cac0bXy0AqvmH2Capalg37bWFtXQLTg==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>skiely@proqr.com<\/u><\/b><\/strong><\/a><br \/> or<br \/> Hans Vitzthum<br \/> LifeSci Advisors<br \/> T: +1 617 430 7578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BDiaCINuxHebRoHLcNrR2BclDfH1EGY3mfw-jFn7QLxxqZ9FNDtD-Jo2fYyHMX8NIMZhjPZeAbd1W6DHxW07P4KY-LF5nYkn5X7ddNY4D3E=\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>hans@lifesciadvisors.com<\/u><\/b><\/strong><\/a><\/p>\n<p>\n        <b>Media contact:<\/b><br \/>\n        <br \/> Robert Stanislaro<br \/> FTI Consulting<br \/> T: +1 212 850 5657<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OxuaiDdXZo7eOAtMKQFox9qVpkvmTUM2QCI9tPzP4Lpq1xvHeeTL0yxiOUMBqXXQe1OVDGonJ_q0L02QxOp5iul2DZhAPsfSv7AlQXTvEeA9-BAXMmqjfaBNSXMExORvbuUAltJlH9xSeM0js6DZuQ==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><b><u>robert.stanislaro@fticonsulting.com<\/u><\/b><\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/OGZjYmE5MTUtNjUyMS00MWEyLTgzZTQtMzI4ZGYwYTkzOTdhLTEwMjI3NDA=\/tiny\/ProQR-Therapeutics-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer\u00ae RNA editing technology platform, today announced that Company management will participate in the following upcoming investor conferences and events. Van Lanschot Kempen Life Sciences Conference \u2013 AmsterdamWednesday, April 26 \u2013 1&#215;1 meetings only JMP Securities Life Sciences Conference \u2013 New YorkTuesday, May 16, 12:30-12:50pm EDT \u2013 Fireside chat and 1&#215;1 meetings Stifel 2023 Tailoring Genes: Genetic Medicines Day \u2013 VirtualTuesday, May 30, time TBC \u2013 Fireside chat only Where applicable, presentation and webcast details will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website under \u201cEvents\u201d. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProQR Announces Upcoming Investor Conferences in April and May&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749501","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProQR Announces Upcoming Investor Conferences in April and May - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProQR Announces Upcoming Investor Conferences in April and May - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer\u00ae RNA editing technology platform, today announced that Company management will participate in the following upcoming investor conferences and events. Van Lanschot Kempen Life Sciences Conference \u2013 AmsterdamWednesday, April 26 \u2013 1&#215;1 meetings only JMP Securities Life Sciences Conference \u2013 New YorkTuesday, May 16, 12:30-12:50pm EDT \u2013 Fireside chat and 1&#215;1 meetings Stifel 2023 Tailoring Genes: Genetic Medicines Day \u2013 VirtualTuesday, May 30, time TBC \u2013 Fireside chat only Where applicable, presentation and webcast details will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website under \u201cEvents\u201d. &hellip; Continue reading &quot;ProQR Announces Upcoming Investor Conferences in April and May&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T12:29:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProQR Announces Upcoming Investor Conferences in April and May\",\"datePublished\":\"2023-04-20T12:29:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/\"},\"wordCount\":791,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/\",\"name\":\"ProQR Announces Upcoming Investor Conferences in April and May - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==\",\"datePublished\":\"2023-04-20T12:29:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-upcoming-investor-conferences-in-april-and-may\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProQR Announces Upcoming Investor Conferences in April and May\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProQR Announces Upcoming Investor Conferences in April and May - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/","og_locale":"en_US","og_type":"article","og_title":"ProQR Announces Upcoming Investor Conferences in April and May - Market Newsdesk","og_description":"LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer\u00ae RNA editing technology platform, today announced that Company management will participate in the following upcoming investor conferences and events. Van Lanschot Kempen Life Sciences Conference \u2013 AmsterdamWednesday, April 26 \u2013 1&#215;1 meetings only JMP Securities Life Sciences Conference \u2013 New YorkTuesday, May 16, 12:30-12:50pm EDT \u2013 Fireside chat and 1&#215;1 meetings Stifel 2023 Tailoring Genes: Genetic Medicines Day \u2013 VirtualTuesday, May 30, time TBC \u2013 Fireside chat only Where applicable, presentation and webcast details will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website under \u201cEvents\u201d. &hellip; Continue reading \"ProQR Announces Upcoming Investor Conferences in April and May\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-20T12:29:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProQR Announces Upcoming Investor Conferences in April and May","datePublished":"2023-04-20T12:29:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/"},"wordCount":791,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/","name":"ProQR Announces Upcoming Investor Conferences in April and May - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==","datePublished":"2023-04-20T12:29:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNDk3NyM0MDE1Mjg4MjUjMjAxMTE2Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-upcoming-investor-conferences-in-april-and-may\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProQR Announces Upcoming Investor Conferences in April and May"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749501"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749501\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}